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Abstract
Background. Myoepitheliomas are tumors composed
predominantly or exclusively of myoepithelial cells, usually
arising in salivary glands. Cutaneous/soft tissue localization
is very rare, especially for the malignant myoepitheliomas.
Case report. We presented a case of myoepithelial carci-
noma involving subcutaneous adipose tissue of the left fo-
rearm in a woman aged 62 years. The tumor was composed
of epithelioid and hyaline cell types, arranged in diffuse she-
ets, nests and loose clusters within hyalinized and myxoid
matrix. The neoplasm displayed high-grade cytologic atypia
with some cells having pleomorphic, hyperchromatic nuclei,
and others showing vesicular nuclei, large nucleoli with
scattered bizarre giant cells. High mean mitotic count of 7
mitoses/10 high power filds and extensive necrosis favou-
red the diagnosis of malignancy. Immunohistochemical
staining was positive for cytokeratin (AE1/AE3), epithelial
membrane antigen, S-100 protein, glial fibrillary acidic pro-
tein, and vimentin. Conclusion. Considering the subcuta-
neous localization, myoepithelial immunophenotype and
high-grade cytologic atypia the neoplasm was classified as a
soft-tissue myoepithelial carcinoma.
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Apstrakt
Uvod. Mioepiteliomi predstavljaju tumore sastavljene pre-
težno, ili isključivo, od mioepitelnih ćelija, koji se uglavnom
javljaju u pljuvačnim žlezdama. Kutana/mekotkivna lokali-
zacija mioepitelioma je vrlo retka, naročito malignih mioe-
pitelioma. Prikaz bolesnika. U radu smo prikazali slučaj
mioepitelnog karcinoma potkožnog masnog tkiva leve pod-
laktice kod žene starosti 62 godine. Tumor je bio izgrađen
od epiteloidnih i hijalnih ćelija u većim i manjim plažama i
nepravilnim, rastresitim grupama unutar hijalinizovanog i
miksoidnog matriksa. Tumorske ćelije su pokazivale atipiju
visokog stepena: pojedine ćelije su se odlikovale pleomor-
fnim, hiperhromnim jedrima, druge, vezikularnim jedrima i
velikim neukleolusima, kao i bizarnim džinovskim oblicima.
Prosečan broj mitoza od 7/10 polja uveličanja i opsežna ne-
kroza upućivali su na maligni tumor. Imunohistohemijsko
bojenje je bilo pozitivno na citokreatin (AE1/AE3), epitelni
membranski antigen (EMA), S-100 protein, glijalni fibrilarni
kiseli protein (glial fibrillary acidic protein) i vimentin. Zaklju-
čak. Na osnovu supkutane lokalizacije, mioepitelnog imu-
nofenotipa i citološke atipije visokog stepena, tumor je kla-
sifikovan kao mioepitelni karcinom mekog tkiva.
Ključne reči:
mioepiteliom; koža; meka tkiva, neoplazme;
imunohistohemija.
Introduction
Benign and malignant neoplasms of myoepithelial cells
comprise a rare, but well-characterized group of tumors, among
which salivary gland myoepitheliomas are the best known 
1–5.
Extrasalivary tumors have been also described in the breast,
lung 
6, 7, and, recently, in the skin and soft tissues 
8–13. Cutaneous
and soft-tissue myoepitheliomas have been considered to be the
monophasic, purely  myoepitheliomatous, variant of cutaneous
mixed tumor (chondroid syringoma) 
10–13. Soft tissue myoepi-
theliomas are rare tumors, histologically mostly benign 
8, 9, 12, 14–
16; malignant myoepitheliomas arising in soft tissues have been
6; malignant myoepitheliomas arising in soft tissues have been
reported only in a series of Hornick and Fletcher 
12.
We report an additional case of soft tissue myoepithe-
lial tumor which exhibited overt histological features of ma-
lignancy.
Case report
Clinical history
A 62-year-old woman presented with a painless mass in
the left forearm. After a 15-year period of slow growth, the
lump suddenly increased in size. Clinical examination re-Strana 612 VOJNOSANITETSKI PREGLED Volumen 63, Broj 5
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vealed a 5-cm-wide, firm, non-tender, circumscribed tu-
mor deep in subcutaneous tissue, with no obvious involve-
ment of the overlying skin. Excision of the lesion with the
surrounding adipose tissue had been carried out and four
months after the excisional biopsy reexcision of the scar site
was performed. After a 12-month follow-up period there was
no evidence of tumor recurrence or metastases.
Tissue samples were fixed in 10% formalin and rou-
tinely processed for microscopic analysis. The 5 μm thick
sections were stained with hematoxylin and eosin, and im-
munostaining was performed using the streptavidin-biotin
technique with DAKO's LSAB+ kit (Dako, Glostrup, Den-
mark). The list of primary antibodies utilized is given in Ta-
ble 1.
Table 1
Immunohistochemical antibody panel used
Antibody specificity Clone Dilution
Keratin AE1/AE3 1 : 100
EMA* E29 Prediluted
S-100 protein Polyclonal 1 : 1 500
GFAP
† Polyclonal Prediluted
Calponin CALP 1 : 200
αSMA
‡ 1A4 1 : 100
MSA
§ HHF35 1 : 50
Desmin D33 1 : 50
Vimentin Vim 3B4 1 : 100
Melanosome HMB-45 1 : 50
*EMA – epithelial membrane antigen; 
†GFAP – glial fibrillary acidic
protein; 
‡αSMA – alpha-smooth muscle actin; 
§MSA – muscle-specific
actin. All primary antibodies supplied by DAKO (Glostrup, Denmark)
Pathological findings
The first specimen received consisted of three irregular
parts of a tumor mass, without the overlying skin, measuring
4 cm, 2 cm, and 1.8 cm in diameter. The largest specimen
had the central necrotic cavity. Histological examination
showed a well delineated, partially encapsulated tumor in the
subcutaneous adipose tissue (Figure 1a).
Fig. 1a – A well circumscribed myoepithelial carcinoma in
subcutaneous adipose tissue (HE, × 40)
Tumor cells were arranged in diffuse sheets and nests
within the hyaline matrix or in small loosely arranged clus-
ters in a myxoid background. These clusters contained small
cystic spaces filled with myxoid material, giving the impres-
sion of pseudo acinar/glandular structures (Figure 1b).
Fig. 1b – The tumor consists of solid nests of tumor cells and
loose clusters of epithelioid and hyaline cells with cystic
spaces (HE, × 200)
True glands and ducts were not present. Large areas of
coagulative necrosis were centrally placed. The tumor con-
sisted of two cell types: epithelioid and hyaline/plasmacytoid
(Figure 1b). Epithelioid cells were round or polygonal with
variable amount of eosinophilic cytoplasm, ill defined cell
borders and centrally placed nuclei. Hyaline cells contained
copious, intensively eosinophilic cytoplasm and peripherally
placed muclei. High-grade cytologic atypia and nuclear
pleomorphism, with enlarged irregular ovoid, hyperchro-
matic nuclei, were found predominantly in the epithelioid
cell-type (Figure 2a).
Fig. 2a – Myoepithelial carcinoma displaying high-grade
cytologic atypia with nuclear pleomorphism (HE, × 400)
Scattered bizarre mono- and multinucleated-giant cells
were also present. In less differentiated portions, the cells dis-
played vesicular nuclei with prominent large nucleoli and the
mitotic count up to 7 mitoses/10 high power fields (HPF) (Fig-
ure 2b). Tumor infiltration into surrounding adipose tissue was
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Fig. 2b – Large prominent nucleoli and up to 5 mitoses/HPF
(arrowheads) within less differentiated areas (HE, × 400)
Immunohistochemistry showed strong positive staining
with cytokeratin (AE1/AE3), epithelial membrane antigen
(Figure 3a), glial fibrillary acidic protein (GFAP) (Figure
3b), S-100 protein, and vimentin. Immunostaining for cal-
ponin, α-smooth muscle actin, muscle-specific actin, desmin,
and HMB-45 was negative.
 
Fig. 3a – Tumor cells showing epithelial membrane antigen
immunopositivity (streptavidin biotin, × 200)
Fig. 3b – Tumor cells showing glial fibrillary acidic protein
immunopositivity (streptavidin biotin, × 200)
The second excisional biopsy of the scar site showed
two small foci of residual tumor in the subcutaneous fat at
the deep margin of the specimen.
Discussion
In the skin, myoepithelial cells are seen mainly around
apocrine and eccrine sweat glands 
11. Morphlogically, the
neoplastic myoepithelial cells may show spindled, epitheli-
oid, hyaline (plasmocytoid) and clear cell features. Such
variations result in the extremely heterogeneous appearances
of myoepitheliomatous neoplasms, with a morphologic con-
tinuum ranging from ductal neoplasms (cutaneous mixed
tumors, or chondroid syringomas) to pure myoepitheliomas
with no ductal differentiation 
9–13, 17, 18. The current view is
that both tumors represent ends of a single spectrum of neo-
plasms with myoepithelial differentiation 
8, 10–13. According
to the similar clinical behavior of chondroid syringoma and
myoepithelioma, the distinction in classification is only use-
ful to recognize their diverse morphology and to avoid con-
fusion with unrelated neoplasms 
12.
The occurrence of myoepitheliomas in soft tissues has
been recently recognized 
8, 9, 12, 14, 19. Soft tissue localization
has been defined as subcutaneous, intramuscular, fascial and
subfascial 
6, where myoepitheliomas are possibly derived
from deeply located, heterotopic adnexal structures 
8, 14. In
1997, Kilpatrick et al. 
8 first described 13 cases of soft tissue
myoepitheliomas, which were included later by Hornick and
Fletcher 
12 into the largest series of myoepithelial tumors of
soft tissue. They classified 35 tumors as myoepithelial carci-
nomas upon histological criteria. Since then, according to the
MEDLINE database, no additional case of soft tissue myo-
epithelial carcinoma has been reported.
In the case described, a diagnosis of myoepithelial car-
cinoma was based on morphological and immunohisto-
chemical features. Malignat chondroid syringoma was ex-
cluded due to the lack of ductal differentiation. According to
Savera et al. 
3 our case could be classified as a mixed cell
type, consisting of hyaline (plasmacytoid) and epithelioid
cells. Myoepithelial cells possess the capacity for epithelial
and myoid differentiation and therefore, variable immunoex-
pression for cytokeratins, EMA, S-100 protein, GFAP, mus-
cle actins, and calponin 
2, 10–13. This case exhibited the im-
munophenotype required for a myoepithelial tumor 
2, 13, be-
ing positive for epithelial markers (cytokeratin and EMA), S-
100 protein and GFAP. The tumor was immunonegative for
myogenic markers. The latter finding does not exclude the
diagnosis of a myoepithelial tumor, as it has been well es-
tablished that neoplastic myoepithelial cells often lose ex-
pression of myogenic markers, and such immunoreactivity is
not required to confirm myoepithelial differentiation 
12, 13.
The prognosis of soft tissue myoepitheliomas is uncer-
tain, although most appear to behave in a benign fashion 
8, 9,
12. Histologic criteria for malignancy in cutaneous/soft tissue
myoepitheliomas have been established 
11–13 analogously to
salivary gland myoepithelial carcinoma 
3, 4 and cutaneous
malignant mixed tumor (malignant chondroid syringoma) 
20–
22. The present case displayed frank histological features ofStrana 614 VOJNOSANITETSKI PREGLED Volumen 63, Broj 5
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malignancy: severe cytologic atypia (nuclear pleomorphism,
enlarged vesicular and hyperchromatic nuclei, large nucle-
oli), high mitotic activity, coagulative necrosis and satellite
tumor nodules. No specific mitotic rate cutoff exists for
making the distinction between benign and malignant myo-
epitheliomas 
8, 12, but > 7 mitoses per 10 HPF was diagnostic
of malignancy in one series 
23, a finding identical to the mean
mitotic count in our case. In a soft tissue myoepithelioma se-
ries of Hornick and Fletcher 
12 there was a statistically sig-
nificant difference in recurrence rate and the frequency of
metastasis between the tumors classified histologically as
benign and malignant, and the only histological feature sig-
nificantly associated with the recurrence or metastasis was
severe cytological atypia. Clearly, myoepithelial tumors of
soft tissue with high-grade cytologic atypia are malignant 
12.
Accordingly, on the basis of high-grade cytologic atypia, we
classified the present case of soft tissue myoepithelial tumor
as a myoepithelial carcinoma, which warranted a close fol-
low-up for early detection of a possible local recurrence or
metastasis.
Conclusion
Considering the subcutaneous localization, myoepithelial
immunophenotype and high-grade cytologic atypia the neo-
plasm was classified as a soft-tissue myoepithelial carcinoma.
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